2017
DOI: 10.1101/167221
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Risk factor profile of different clinical manifestations of cerebral small vessel disease - data from SHEF-CSVD Study

Abstract: BACKGROUND:

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 37 publications
(35 reference statements)
0
2
0
Order By: Relevance
“…WMH are a type of sporadic small vascular disease, and axon loss and demyelination are the causes of WMH, which may be the result of chronic ischemia caused by CSVD (Staszewski et al, 2015). It is also believed that hypoperfusion is related to cerebral vascular autoregulation changes or blood-brain barrier dysfunction (Simpson et al, 2007), inflammation, and amyloid vascular disease (Gouw et al, 2011).…”
Section: Association Of Wmh With Gait and Balancementioning
confidence: 99%
“…WMH are a type of sporadic small vascular disease, and axon loss and demyelination are the causes of WMH, which may be the result of chronic ischemia caused by CSVD (Staszewski et al, 2015). It is also believed that hypoperfusion is related to cerebral vascular autoregulation changes or blood-brain barrier dysfunction (Simpson et al, 2007), inflammation, and amyloid vascular disease (Gouw et al, 2011).…”
Section: Association Of Wmh With Gait and Balancementioning
confidence: 99%
“…We acknowledge that reactivity can be calculated with (Claassen et al, 2007) and without (Silvestrini et al, 2000;Staszewski et al, 2018;Thibeault et al, 2018) factoring P ET CO 2 , while still collecting and monitoring CO 2 for compliance. Measuring P ET CO 2 during a complete breath-holding task is not possible.…”
Section: Author Manuscriptmentioning
confidence: 99%